EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ ミツトヨ
@ エスペック
@ トプコン
@ メディキット
@ マニー
@ JMS
@ SEIKO HOLDINGS
@ NIHON TRIM
@ Hitachi Medical
@ NIDEC TOSOK
@ TOKYO KEIKI
@ Aichi Tokei Denki
@ Rigaku
@ タムロン
@ Noritsu Koki
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
PIONEER
graph
クラリオン
graph
クラリオン
graph
クラリオン
graph
クラリオン
graph

Credit Rating Analysis: TOKYO SEIMITSU (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): TOKYO SEIMITSU (Annual ) Consolidated | Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2013-03-31  B  Credit is not enough, easily undermined by biz environs. ¥ 51 B
-11.63%
¥ 7 B
-15.14%
¥ 3 B
-53.58%

Financial Timeline

Date  2012-12-31 
(Third quarter )
 2013-03-31 
(Annual )
 2013-06-30 
(First quarter )
 2013-09-30 
(Second quarter )
Credit Rating BBBBBBAA
Total Assets
¥ 77 B
¥ 77 B
¥ 79 B
¥ 79 B
Net Assets
¥ 55 B
¥ 57 B
¥ 59 B
¥ 60 B

Financial Statement Risk Analysis: TOKYO SEIMITSU (Annual ) (Consolidated )

[Date: 2013-03-31]  Danger : Warning : Caution : Good
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -4 B) is a minus, Issuance of new shares (¥ 1 M) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Management Risk (*Sales is decrease )
Sales (¥ 51 B) is first term Sales (¥ 57 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Income is decrease )
Net Income (¥ 3 B) is first term Net Income (¥ 8 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (7.83%) is first term Net Profit Margin (14.91%) less , there is a possibility that the profitability has deteriorated.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -3 B) & Financial Cash Flow (¥ -4 B) is a minus, Operating Cash Flow (¥ 8 B) is a plus,
Dividend
Under the situation of Net Income (¥ 3 B) & Operating Cash Flow (¥ 8 B) , Dividend (¥ -659 M) is paid.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -2 B) is Sales first term ratio (¥ -6 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2012-03-31]  Danger : Warning : Caution : Good
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -5 B) is a minus, Issuance of new shares (¥ 12 M) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -3 B) & Financial Cash Flow (¥ -5 B) is a minus, Operating Cash Flow (¥ 8 B) is a plus,
Dividend
Under the situation of Net Income (¥ 8 B) & Operating Cash Flow (¥ 8 B) , Dividend (¥ -535 M) is paid.
[Date: 2011-03-31]  Danger : Warning : Caution : Good
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -4 B) is a minus, Issuance of new shares (¥ 22 M) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 1 B) is a plus, Issuance of new shares (¥ 22 M) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.
Dividend
Under the situation of Net Income (¥ 6 B) & Operating Cash Flow (¥ 7 B) , Dividend (¥ -206 M) is paid.
[Date: 2010-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income & Sales is sharp decrease )
As compared with the first term of Sales (¥ 30 B) , Sales (¥ 45 B) is less than 80%, and As compared with the first term of Net Income (¥ -11 B) , Net Income (¥ -3 B) is less than 10%, , there is a possibility that the management situation has deteriorated very much.
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -8 B) is a minus, Issuance of new shares (¥ 1 B) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Management Risk (*Sales is decrease )
Sales (¥ 30 B) is first term Sales (¥ 45 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Gross Income is decrease )
Gross Income (¥ 26 B) is first term Gross Income (¥ 37 B) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Risk (*Issuance of new shares)
Investment Cash Flow (¥ 1 B) is a plus, Issuance of new shares (¥ 1 B) is plus. Because it is thought that the circulating fund is gained by sale and new issue of stocks of stock property , there is a possibility that the financing is severe.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -2 B) is Sales first term ratio (¥ -15 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2009-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -11 B) is minus or 0, so , there is a possibility that the management situation is severe.
Dividend Risk
Under the situation of Net Income (¥ -11 B) & Operating Cash Flow (¥ 2 B), Dividend (¥ -2 B) is paid.
Overinvestment Risk (*Investment Cash Flow confirmed content)
Net Income (¥ -11 B) is a minus, the cashflow of Operating Cash Flow (¥ 2 B) is smaller than Investment Cash Flow (¥ -3 B) , there is a possibility of the overinvestment.

Related Information: TOKYO SEIMITSU (Annual )

Statement Type
Annual : TOKYO SEIMITSU
First quarter : TOKYO SEIMITSU
Second quarter : TOKYO SEIMITSU
Third quarter : TOKYO SEIMITSU
Analysis Menu
@Outline : TOKYO SEIMITSU
@Statement : TOKYO SEIMITSU
@Rating : TOKYO SEIMITSU
@Indicator : TOKYO SEIMITSU
@Download : TOKYO SEIMITSU
Industry Comparison Ranking
Precision Instruments - EDIUNET Industry Rankings
Precision Instruments - EDIUNET Credit Rating
Precision Instruments - EDIUNET Industry Avg
Comparison with a neighboring company
Tokyo - EDIUNET Prefectures
Tokyo八王子市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/15 シグマ光機 BBB 2013-11-30 (Q2)
1/15 RORZE B→BB 2013-11-30 (Q3)
1/9 スター精密 BB 2013-11-30 (Q3)
1/7 マニー AA 2013-11-30 (Q1)
12/13 インスペック C 2013-10-31 (Q2)
12/5 三井ハイテック A→AA 2013-10-31 (Q3)
12/5 アルチザネットワークス BB→BBB 2013-10-31 (Q1)
11/14 asahi intecc BBB→A 2013-09-30 (Q1)
11/14 黒田精工 B→CCC 2013-09-30 (Q2)
11/14 Precision Sysem Science CCC→BBB 2013-09-30 (Q1)

Ticker Market Industry Month report Rating
@ TOKYO SEIMITSU 7729 TSE 1st Precision Instruments 3 Annual B

Related Company

@ TOKYO KEIKI (Sales ¥ 40 B)
@ Shimadzu (Sales ¥ 264 B)
@ JMS (Sales ¥ 49 B)
@ メディキット (Sales ¥ 13 B)
@ スター精密 (Sales ¥ 37 B)
@ NIDEC TOSOK (Sales ¥ 31 B)
@ ミツトヨ (Sales ¥ 80 B)
@ RHYTHM WATCH (Sales ¥ 32 B)
@ ONO SOKKI (Sales ¥ 11 B)
@ SEIKO HOLDINGS (Sales ¥ 283 B)
@ Hitachi Medical (Sales ¥ 159 B)
@ RIKEN KEIKI (Sales ¥ 19 B)
@ KOKUSAI (Sales ¥ 10 B)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.083 sec.)